| 国产哌拉西林-他唑巴坦治疗支气管扩张症合并感染的疗效观察 |
| |
| 引用本文： | 吕晓红,彭丽萍,丁会,华树成. 国产哌拉西林-他唑巴坦治疗支气管扩张症合并感染的疗效观察[J]. 世界临床药物, 2010, 31(1): 21-24 |
| |
| 作者姓名： | 吕晓红 彭丽萍 丁会 华树成 |
| |
| 作者单位： | 吉林大学第一医院呼吸内科,长春,130021 |
| |
| 摘 要： | 目的评价国产哌拉西林-他唑巴坦治疗支气管扩张症合并感染的疗效和安全性。方法98例支气管扩张症合并感染患者随机分为2组，组1（50例）静脉滴注哌拉西林-他唑巴坦（国产）；组2（48例）静脉滴注头孢哌酮钠-舒巴坦钠（合资），疗程均为7d。结果两组治疗支气管扩张症合并感染的临床有效率和细菌清除率分别为90．00％对91．68％，87．18％对90．00％，不良反应发生率分别为6．00％和4．17％，两组相比差异均无统计学意义（P〉0．05）。结论国产哌拉西林-他唑巴坦治疗支气管扩张症合并感染的疗效和安全性与头孢哌酮钠-舒巴坦钠相当，安全有效。
|
| 关 键 词： | 哌拉西林-他唑巴坦 支气管扩张症 感染 |
The effect of piperacillin-tazobactam in the treatment of bronchiectasis complicating infections |
| |
| LV Xiao-hong,PENG Li-ping,DING Hui,HUA Shu-cheng. The effect of piperacillin-tazobactam in the treatment of bronchiectasis complicating infections[J]. WORLD CLINICAL DRUGS, 2010, 31(1): 21-24 |
| |
| Authors: | LV Xiao-hong PENG Li-ping DING Hui HUA Shu-cheng |
| |
| Affiliation: | Department of Respiratory Medicine;First Hospital;University of Jilin;Changchun 130021;China |
| |
| Abstract: | Objective To evaluate the clinical effectiveness and safety of piperacillin-tazobactam in the treatment of bronchiectasis combining infections.Methods Ninty-eight patients with bronchiectasis complicating infections were randomly divided into two groups.7-day courses of piperacillin-tazobactam(n=50) or cefperazone-sulbactam(n=48) were administered by intravenous infusion respectively.Results The clinical efficacy rate and the bacterial elimination rate in two groups were 90.00%vs 91.68%,87.18%vs 90.00%respe... |
| |
| Keywords: | piperacillin-tazobactam bronchiectasis infection |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
